Merck has struck a deal worth up to $1.3 billion to buy an investigational drug targeting B-cell associated diseases.
Related Posts
Canada to Provide $720 Million to Canada Post to Avoid Insolvency at Mail Service
- staff
- January 24, 2025
- 0
The Canadian government said it would provide extraordinary financing to Canada Post to avoid insolvency at the state-owned mail service.
Cerence Names Ex-Intel Chief Krzanich CEO
The chief executive of Cerence has stepped down and will be succeeded by Brian Krzanich, the former chief of Intel and CDK Global.
GSK, China’s Zhifei Expand Shingles Shot Collaboration
GSK extended its collaboration with Zhifei to commercialize its shingles vaccine Shingrix in China until 2034.